{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:48:02Z","timestamp":1789048082049,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.eururo.2009.07.027","type":"journal-article","created":{"date-parts":[[2009,7,30]],"date-time":"2009-07-30T10:57:40Z","timestamp":1248951460000},"page":"821-829","source":"Crossref","is-referenced-by-count":67,"title":["Should Pathologists Routinely Report Prostate Tumour Volume? The Prognostic Value of Tumour Volume in Prostate Cancer"],"prefix":"10.1016","volume":"57","author":[{"given":"Tineke","family":"Wolters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique J.","family":"Roobol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pim J.","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick C.N.","family":"van den Bergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Hoedemaeker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert J.L.H.","family":"van Leenders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fritz H.","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodorus H.","family":"van der Kwast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2009.07.027_bib1","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1001\/jama.281.15.1395","article-title":"Biological determinants of cancer progression in men with prostate cancer","volume":"215","author":"Stamey","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2009.07.027_bib2","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/01.ju.0000130481.04082.1a","article-title":"Is tumor volume an independent prognostic factor in clinically localized prostate cancer?","volume":"172","author":"Kikuchi","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2009.07.027_bib3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1309\/AJCPX5MAMNMFE6FQ","article-title":"Percentage of tumor in prostatectomy specimens","volume":"131","author":"Vollmer","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.eururo.2009.07.027_bib4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(86)90715-4","article-title":"Patterns of progression in prostate cancer","volume":"1","author":"McNeal","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2009.07.027_bib5","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/S0022-5347(17)36421-2","article-title":"Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of follow-up","volume":"149","author":"Epstein","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2009.07.027_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0302-2838(02)00493-1","article-title":"Prognostic significance of tumor volume after radical prostatectomy: a multivariate analysis of pathological prognostic factors","volume":"43","author":"Salomon","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2009.07.027_bib7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/01.ju.0000132139.40964.75","article-title":"Percent carcinoma in prostatectomy specimens is associated with risk of recurrence after radical prostatectomy in patients with pathologically organ confined prostate cancer","volume":"172","author":"Ramos","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2009.07.027_bib8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0090-4295(93)90617-J","article-title":"Radical prostatectomy for pathologic stage C prostate cancer: influence of pathologic variables and adjuvant treatment on disease outcome","volume":"43","author":"Cheng","year":"1993","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2009.07.027_bib9","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.urology.2007.03.062","article-title":"Tumor volume does not predict for biochemical recurrence after radical prostatectomy in patients with surgical Gleason score 6 or less prostate cancer","volume":"70","author":"Merrill","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2009.07.027_bib10","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0022-5347(17)42736-4","article-title":"Tumor volume versus percentage of specimen involved by tumor correlated with progression in stage A prostatic carcinoma","volume":"139","author":"Epstein","year":"1988","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2009.07.027_bib11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0022-5347(17)40761-0","article-title":"Morphometric measurement of tumor volume and percent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer","volume":"141","author":"Partin","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2009.07.027_bib12","series-title":"TNM classification of malignant tumours","year":"2002"},{"key":"10.1016\/j.eururo.2009.07.027_bib13","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/cncr.20145","article-title":"Biochemical failure after radical prostatectomy in men with pathologic organ-confined disease: pT2a versus pT2b","volume":"100","author":"Freedland","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2009.07.027_bib14","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1464-410X.2008.07897.x","article-title":"Evaluation of pT2 subdivisions in the TNM staging system for prostate cancer","volume":"102","author":"Hong","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2009.07.027_bib15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1385\/JUP:9:3:211","article-title":"Processing radical prostatectomy specimens. A comprehensive and standardized protocol","volume":"9","author":"Hoedemaeker","year":"1998","journal-title":"J Urol Pathol"},{"key":"10.1016\/j.eururo.2009.07.027_bib16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF01300181","article-title":"Comparison of pathological characteristics of T1c and non-T1c cancers detected in a population-based screening study, the European Randomized Study of Screening for Prostate Cancer","volume":"15","author":"Hoedemaeker","year":"1997","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2009.07.027_bib17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0090-4295(02)02268-9","article-title":"Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy","volume":"61","author":"Freedland","year":"2003","journal-title":"Urology"},{"issue":"Suppl 2","key":"10.1016\/j.eururo.2009.07.027_bib18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1465-5101.2003.04402.x","article-title":"Determining the cause of death in randomized screening trial(s) for prostate cancer","volume":"92","author":"De Koning","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2009.07.027_bib19","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/1097-0142(19930201)71:3+<933::AID-CNCR2820711408>3.0.CO;2-L","article-title":"Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer","volume":"71","author":"Stamey","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2009.07.027_bib20","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.juro.2006.08.007","article-title":"Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings","volume":"176","author":"Villers","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2009.07.027_bib21","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00330-008-1153-0","article-title":"Dynamic contrast-enhanced MRI of anterior prostate cancer: morphometric assessment and correlation with radical prostatectomy findings","volume":"19","author":"Lemaitre","year":"2009","journal-title":"Eur Radiol"},{"key":"10.1016\/j.eururo.2009.07.027_bib22","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.eururo.2006.06.025","article-title":"How good is MRI at detecting and characterizing cancer within the prostate?","volume":"50","author":"Kirkham","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2009.07.027_bib23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1148\/radiol.2231010575","article-title":"Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging","volume":"223","author":"Coakley","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.eururo.2009.07.027_bib24","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.eururo.2006.07.051","article-title":"Should we replace the Gleason score with the amount of high-grade prostate cancer?","volume":"51","author":"Vis","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2009.07.027_bib25","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/00000478-200310000-00001","article-title":"A streamlined three-dimensional volume estimation method accurately classifies prostate tumors by volume","volume":"27","author":"Chen","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2009.07.027_bib26","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.urology.2005.05.037","article-title":"Maximal tumor diameter and the risk of PSA failure in en with specimen-confined prostate cancer","volume":"66","author":"Dvorak","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2009.07.027_bib27","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/modpathol.3800405","article-title":"Maximum tumor diameter is an independent predictor of prostate specific antigen recurrence in prostate cancer","volume":"18","author":"Eichelberger","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.eururo.2009.07.027_bib28","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/01.pas.0000213429.61374.4f","article-title":"Positive-block ratio in radical prostatectomy specimens is an independent predictor of prostate-specific antigen recurrence","volume":"31","author":"Marks","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2009.07.027_bib29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1590\/S1677-55382003000200004","article-title":"Correlation between tumor extent in radical prostatectomies and preoperative PSA, histological grade, surgical margins and extraprostatic extension; application of a new practical method for tumor extent evaluation","volume":"29","author":"Billis","year":"2003","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.eururo.2009.07.027_bib30","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/1097-0142(20000915)89:6<1308::AID-CNCR16>3.0.CO;2-3","article-title":"Visual estimate of the percentage of carcinoma is an independent predictor of prostate carcinoma recurrence after radical prostatectomy","volume":"89","author":"Carvalhal","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2009.07.027_bib31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00345-008-0242-7","article-title":"Maximum tumor diameter is not an independent prognostic factor in high-risk localized prostate cancer","volume":"26","author":"van Oort","year":"2008","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2009.07.027_bib32","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1464-410X.2006.06204.x","article-title":"Pathological changes if high-grade prostatic intraepithelial neoplasia and prostate cancer after monotherapy with bicalutamide 150mg","volume":"98","author":"Scattoni","year":"2006","journal-title":"BJU Int"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283809007830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283809007830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T15:55:58Z","timestamp":1558454158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283809007830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0302283809007830"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2009.07.027","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}